Clorox (CLX) — officially The Clorox Company — has been one of the more heavily debated names in consumer staples over the past year. After trading near $129 in early 2026, the stock has pulled back sharply and recently changed hands around the mid-$90s, leaving many investors asking whether a recovery back toward the $120 level is realistic. That price target sits roughly 25% above current levels and would require a meaningful improvement in both earnings momentum and market sentiment.
Clorox is a household-products company whose portfolio includes cleaning and disinfecting brands such as Clorox, Pine-Sol, Formula 409, and Liquid-Plumr, alongside categories like Glad trash bags, Hidden Valley, and the professional/healthcare products acquired with GOJO. The stock is widely regarded as a defensive, dividend-oriented holding: it currently offers a forward dividend near $5.00 per share, translating to a yield of roughly 5%, which is well above the broader market average.
At recent levels, CLX trades at a price-to-earnings (P/E) ratio near 19 times trailing earnings. The stock's 52-week range of approximately $85 to $129 underscores just how far sentiment has swung. The shares remain far below their all-time high near $240 reached in 2020 during the peak of pandemic-era demand for cleaning products.
The $120 level matters for two reasons. First, it is a round psychological milestone that sits just beneath the stock's recent 52-week high near $129, making it a natural point where long-term holders who bought into the 2025–2026 strength might look to reduce positions. Second, it aligns roughly with the upper end of several analyst price targets, including calls from firms that have maintained more constructive views on the company. Reaching $120 would signal that Clorox has convincingly moved past its recent operational setbacks.
The most credible path toward $120 runs through margin and volume recovery. Clorox's gross margin, near 42%, and its net profit margin in the high single digits leave room for improvement if input-cost pressures ease and if the company can pass through pricing without further losing share to private labels. The GOJO acquisition adds a higher-margin, professional-use business — including the Purell brand — that management views as a long-term growth and margin lever.
Clorox is also still working through the aftermath of a 2023 cyberattack and a multi-year enterprise resource planning (ERP) system modernization. As those disruptions normalize, analysts have noted the potential for steadier execution, inventory rebuilds, and a return to more predictable sales trends. A stabilization in consumer spending, combined with the stock's roughly 5% yield, could also attract income-focused investors back into the name.
The bear case is rooted in growth, not liquidity. Organic sales have been weak, and Clorox has struggled to push higher costs through to consumers without accelerating the shift toward cheaper store brands — a structural challenge across the household-products category. The ERP transition, while necessary, has repeatedly clouded near-term results and created execution uncertainty.
Valuation adds a second layer of resistance. Even after the decline, Clorox trades at a P/E near 19, which is not obviously cheap for a company delivering little to no organic revenue growth. Goldman Sachs has maintained a Sell rating with a target near $77, while several firms have trimmed targets into the $90–$100 range, reflecting skepticism about the speed of any recovery.
The consensus among analysts covering Clorox is a "Hold," with an average 12-month price target near $101.65. The range is unusually wide, spanning from a low near $77 to a high near $154, which reflects genuine disagreement about the company's trajectory. Most firms cluster their targets in the $90–$110 range, meaning a move to $120 would require Clorox to outperform the Street's base-case expectations by a considerable margin.
From a technical analysis perspective, the stock's recent decline has left it testing the lower portion of its 52-week range, with a notable support level near $85. On the upside, any sustained move toward $120 would first need to reclaim the $105–$110 zone, which previously acted as a consolidation area and now represents a potential resistance level. The $120 target itself coincides with a supply zone created by the 2026 highs, suggesting sellers could emerge before the level is reached.
For traders monitoring whether CLX can regain momentum toward the $120 price target, Tickeron's AI Daily Buy/Sell Signals offer a data-driven complement to traditional analysis. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and identify shifting market trends more efficiently than manual screening alone.
A move to $120 is possible but far from assured. The strongest supporting factors are Clorox's defensive product portfolio, its roughly 5% dividend yield, and the long-run potential of the GOJO integration and ERP recovery. The primary obstacles are persistent organic-sales weakness, private-label competition, and a consensus analyst target that sits roughly 25% below the $120 level. Investors should monitor gross-margin trends, any evidence of volume stabilization, and the company's progress on its systems overhaul. Without a credible return to organic growth, $120 is likely to remain an upside scenario rather than a near-term reality.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CLX has been loosely correlated with PG. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CLX jumps, then PG could also see price increases.